Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Van Assche

Showing results (151-160 of 287) with videos related to

Pageof 29
Sort By:
Inflammatory Bowel Diseases|August 28, 2015
The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis ProfileLize Bollen, Niels Vande Casteele, Miet Peeters, et al.
Immunity, Inflammation and Disease|June 23, 2020
Fibrogenesis in chronic murine colitis is independent of innate lymphoid cellsBrecht Creyns, Jonathan Cremer, Gert De Hertogh, et al.
The New England Journal of Medicine|June 11, 2005
Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's diseaseGert Van Assche, Marc Van Ranst, Raf Sciot, et al.
Pediatric Transplantation|March 14, 2012
Portal hypertension after combined liver and intestinal transplantation, a diagnostic and therapeutic challenge?Diethard Monbaliu, Jo Vandersmissen, Gert De Hertogh, et al.
Gastroenterology|May 16, 2006
The value of myenteric plexitis to predict early postoperative Crohn's disease recurrenceMarc Ferrante, Gert de Hertogh, Tibor Hlavaty, et al.
Gastroenterology|April 29, 2008
Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trialGert Van Assche, Charlotte Magdelaine-Beuzelin, Geert D'Haens, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Development of pouchitis following ileal pouch-anal anastomosis (IPAA) for ulcerative colitis: A role for serological markers and microbial pattern recognition receptor genesMarc Ferrante, Sarah Declerck, Tamara Coopmans, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 10, 2020
Rates of Postoperative Recurrence of Crohn's Disease and Effects of Immunosuppressive and Biologic TherapiesPauline Rivière, Séverine Vermeire, Marie Irles-Depe, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 26, 2019
Expression Levels of 4 Genes in Colon Tissue Might Be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel DiseasesBram Verstockt, Sare Verstockt, Marisol Veny, et al.
Inflammatory Bowel Diseases|September 7, 2006
The role of vascular endothelial growth factor (VEGF) in inflammatory bowel diseaseMarc Ferrante, Marie Pierik, Liesbet Henckaerts, et al.
Pageof 29

Showing results (151-160 of 287) with videos related to

Sort By:
Pageof 29
Inflammatory Bowel Diseases|August 28, 2015
The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis ProfileLize Bollen, Niels Vande Casteele, Miet Peeters, et al.
Immunity, Inflammation and Disease|June 23, 2020
Fibrogenesis in chronic murine colitis is independent of innate lymphoid cellsBrecht Creyns, Jonathan Cremer, Gert De Hertogh, et al.
The New England Journal of Medicine|June 11, 2005
Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's diseaseGert Van Assche, Marc Van Ranst, Raf Sciot, et al.
Pediatric Transplantation|March 14, 2012
Portal hypertension after combined liver and intestinal transplantation, a diagnostic and therapeutic challenge?Diethard Monbaliu, Jo Vandersmissen, Gert De Hertogh, et al.
Gastroenterology|May 16, 2006
The value of myenteric plexitis to predict early postoperative Crohn's disease recurrenceMarc Ferrante, Gert de Hertogh, Tibor Hlavaty, et al.
Gastroenterology|April 29, 2008
Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trialGert Van Assche, Charlotte Magdelaine-Beuzelin, Geert D'Haens, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Development of pouchitis following ileal pouch-anal anastomosis (IPAA) for ulcerative colitis: A role for serological markers and microbial pattern recognition receptor genesMarc Ferrante, Sarah Declerck, Tamara Coopmans, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 10, 2020
Rates of Postoperative Recurrence of Crohn's Disease and Effects of Immunosuppressive and Biologic TherapiesPauline Rivière, Séverine Vermeire, Marie Irles-Depe, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 26, 2019
Expression Levels of 4 Genes in Colon Tissue Might Be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel DiseasesBram Verstockt, Sare Verstockt, Marisol Veny, et al.
Inflammatory Bowel Diseases|September 7, 2006
The role of vascular endothelial growth factor (VEGF) in inflammatory bowel diseaseMarc Ferrante, Marie Pierik, Liesbet Henckaerts, et al.
Pageof 29